Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular-based compartmental resection of anterior clinoidal meningiomas: an inter-perforator microdebulking strategy.

Acta neurochirurgica·2026
Same author

Refined Endoscopic Extracapsular Resection Technique for Pituitary Adenomas With Suprasellar Extension: A Retrospective Analysis of 259 Cases.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Recurrent ophthalmic arteries supplying posterior meningiomas: embryologic background and 3D anatomical visualization.

BMC surgery·2026
Same author

IgG4-related Disease Affecting Multiple Organs Despite Normal Serum IgG4 Levels.

Internal medicine (Tokyo, Japan)·2026
Same author

Factors Associated with the Acceptance of Communication Robots Among Formal Caregivers in Home-Based Care.

Studies in health technology and informatics·2026
Same author

A Comprehensive Three-Dimensional Simulation Method for Skull Base Meningioma Surgery.

Cureus·2026

Related Experiment Video

Updated: Jul 4, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Drug interaction prediction using ontology-driven hypothetical assertion framework for pathway generation followed by

Takeshi Arikuma1, Sumi Yoshikawa, Ryuzo Azuma

  • 1Department of Computer Science, Tokyo Institute of Technology, 2-12-1 Oookayama, Meguro, Tokyo, Japan. atake@bio.cs.titech.ac.jp

BMC Bioinformatics
|June 27, 2008
PubMed
Summary

This study introduces an Ontology-Driven Hypothetic Assertion framework for predicting drug interactions. The framework accurately identifies potential interactions and estimates side effects, paving the way for personalized medicine.

Related Experiment Videos

Last Updated: Jul 4, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Area of Science:

  • Bioinformatics
  • Pharmacology
  • Computational Biology

Background:

  • In silico prediction of drug interactions is crucial due to individual differences in drug response.
  • Conventional pathway models have limitations in identifying new drug interactions.
  • Integrating molecular events is key for inferring pathways and predicting drug interactions.

Purpose of the Study:

  • To propose a novel Ontology-Driven Hypothetic Assertion (OHA) framework for predicting drug interactions.
  • To dynamically generate metabolic pathways and detect potential drug interactions.
  • To estimate the severity of side effects through numerical simulation.

Main Methods:

  • Developed an OHA framework encompassing pathway generation, drug interaction detection, and simulation.
  • Utilized a Drug Interaction Ontology (DIO) in Web Ontology Language (OWL).
  • Demonstrated the framework using irinotecan and ketoconazole interactions.

Main Results:

  • The OHA framework automatically detected four drug interactions involving CYP3A4 and albumin.
  • Numerical simulation quantified the effects of CYP3A4 interactions, predicting increased SN-38 AUC and Cmax.
  • Genetic variations (UGT1A1*28/*28) were shown to significantly alter SN-38 pharmacokinetics.

Conclusions:

  • The OHA framework shows promise for in silico drug interaction prediction.
  • Future research should expand the DIO and incorporate virtual populations for genetic variation analysis.
  • Refinement of pathway generation, interaction detection, and simulation models is recommended.